These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2253609)

  • 21. Strategies for the identification of rodent carcinogens by in vitro short-term tests.
    Zeiger E
    Prog Clin Biol Res; 1990; 340D():261-71. PubMed ID: 2371299
    [No Abstract]   [Full Text] [Related]  

  • 22. Integrated approach to testing and assessment for predicting rodent genotoxic carcinogenicity.
    Petkov PI; Schultz TW; Donner EM; Honma M; Morita T; Hamada S; Wakata A; Mishima M; Maniwa J; Todorov M; Kaloyanova E; Kotov S; Mekenyan OG
    J Appl Toxicol; 2016 Dec; 36(12):1536-1550. PubMed ID: 27225589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 4.3 In-vitro genotoxicity tests to detect carcinogenicity: a systematic review.
    Müller L
    Hum Exp Toxicol; 2009 Feb; 28(2-3):131-3. PubMed ID: 19713378
    [No Abstract]   [Full Text] [Related]  

  • 24. Genetic toxicology at the crossroads--a personal view on the deployment of short-term tests for predicting carcinogenicity.
    Bridges BA
    Mutat Res; 1988; 205(1-4):25-31. PubMed ID: 3367919
    [No Abstract]   [Full Text] [Related]  

  • 25. Allergic contact dermatitis and its relationship to carcinogenicity.
    Rosenkranz HS
    Mutat Res; 2001 Nov; 483(1-2):51-5. PubMed ID: 11600132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mode of action considerations in the use of transgenic animals for mutagenicity and carcinogenicity evaluations.
    Gollapudi BB; Stott WT; Yano BL; Bus JS
    Toxicol Lett; 1998 Dec; 102-103():479-84. PubMed ID: 10022299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An opinion on the significance of the 19 non-clastogenic gene-mutagens reported by Tennant et al. (1987).
    Ashby J
    Mutagenesis; 1988 Nov; 3(6):463-5. PubMed ID: 3070284
    [No Abstract]   [Full Text] [Related]  

  • 28. International Commission for Protection Against Environmental Mutagens and Carcinogens. Approaches to SAR in carcinogenesis and mutagenesis. Prediction of carcinogenicity/mutagenicity using MULTI-CASE.
    Klopman G; Rosenkranz HS
    Mutat Res; 1994 Feb; 305(1):33-46. PubMed ID: 7508546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re: analysis of pharmaceutical experience with decades of rat carcinogenicity testing. Introduction to article by Sistare et al.
    Morton D; Alden CL
    Toxicol Pathol; 2011 Jun; 39(4):715. PubMed ID: 21666102
    [No Abstract]   [Full Text] [Related]  

  • 30. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP.
    Ashby J; Tennant RW
    Mutat Res; 1991 May; 257(3):229-306. PubMed ID: 1707500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of tests in yeasts and fungi in the detection and evaluation of carcinogens.
    Parry JM
    IARC Sci Publ; 1999; (146):471-85. PubMed ID: 10353399
    [No Abstract]   [Full Text] [Related]  

  • 32. Epidemiological and experimental applications to occupational cancer prevention.
    Vainio H; Hemminki K
    J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of the genotoxicity and carcinogenicity of 4,4'-methylene-dianiline and 4,4'-methylene-bis-2-chloroaniline.
    McQueen CA; Williams GM
    Mutat Res; 1990 Sep; 239(2):133-42. PubMed ID: 2200958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Examples of uses of databases for quantitative and qualitative correlation studies between genotoxicity and carcinogenicity.
    Parodi S; Malacarne D; Taningher M
    Environ Health Perspect; 1991 Dec; 96():61-6. PubMed ID: 1820280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implications of newly recognized relationships between mutagenicity, genotoxicity and carcinogenicity of molecules.
    Rosenkranz HS; Zhang YP; Klopman G
    Mutat Res; 1991; 250(1-2):25-33. PubMed ID: 1944342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic toxicology data in the evaluation of potential human environmental carcinogens.
    Waters MD; Stack HF; Jackson MA
    Mutat Res; 1999 Jul; 437(1):21-49. PubMed ID: 10425388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contemporary trends in in vivo and in vitro testing of chemical carcinogens.
    Slamenová D
    Neoplasma; 2001; 48(6):425-34. PubMed ID: 11949832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of cancer potency using a battery of mutation and toxicity data.
    Travis CC; Saulsbury AW; Pack SA
    Mutagenesis; 1990 May; 5(3):213-9. PubMed ID: 2385175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints.
    Matthews EJ; Kruhlak NL; Cimino MC; Benz RD; Contrera JF
    Regul Toxicol Pharmacol; 2006 Mar; 44(2):83-96. PubMed ID: 16386343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods.
    Matthews EJ; Kruhlak NL; Cimino MC; Benz RD; Contrera JF
    Regul Toxicol Pharmacol; 2006 Mar; 44(2):97-110. PubMed ID: 16352383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.